✓ No loaded language, vague sourcing, or framing detected.
A report by congressional Democrats indicates that former President Trump's pharmaceutical stock holdings increased significantly, rising from $1.7 million in 2024 to $56.2 million by the end of 2025.
Our neutral summary
A report by congressional Democrats indicates that former President Trump's pharmaceutical stock holdings increased significantly, rising from $1.7 million in 2024 to $56.2 million by the end of 2025.
The reporting belongs to PBS NewsHour; we don't reproduce it.
No note attached
on this article.
Democrats say Trump increased investments in drugmakers that were given Medicare exemptions
Democrats report increase in Trump's pharmaceutical stock holdings